LCG
GDRX icon

Luxor Capital Group’s GoodRx Holdings GDRX Stock Holding History

Luxor Capital Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-583,881
Closed -$21M – 174
2021
Q2 		$21M Buy
+583,881
New +$21.5M 0.23% 42

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Luxor Capital Group's GDRX Position: Q3 2021 in Review

Luxor Capital Group sold out of GoodRx Holdings (GDRX) in Q3 2021, closing a stake of 583,881 shares — an estimated $21M sold.

Luxor Capital Group first reported a position in GDRX in Q2 2021 and held it in 1 quarter. The position peaked at $21M in Q2 2021. 218 funds tracked by Wall St. Rank hold GDRX as of Q3 2021.

  • Luxor Capital Group reported no remaining GoodRx Holdings position as of Q3 2021 after selling out during the quarter.
  • Luxor Capital Group sold 583,881 GoodRx Holdings shares in Q3 2021, an estimated $21M.
  • Luxor Capital Group first reported a position in GoodRx Holdings in Q2 2021 and held it in 1 quarter.
  • Luxor Capital Group's GoodRx Holdings position peaked at $21M in Q2 2021.
  • 218 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2021.

Based on Luxor Capital Group's 13F filing for Q3 2021, filed 15 Nov 2021.